The urokinase-type plasminogen activator (uPA) receptor (uPAR) and its ligand uPA are involved in numerous physiological and pathological processes including pericellular proteolysis, wound healing, tissue regeneration and tumor progression [1–3]. This evidence concerns the gene PLAU and neoplasm.